世界の心臓モニタリング＆心臓律動管理システム市場...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1 INCREASING INCIDENCE OF LIFESTYLE DISEASES & CARDIOVASCULAR DISEASES
3.2.1.2 TECHNOLOGICAL ADVANCES & REMOTE MONITORING
3.2.1.3 GOVERNMENT REGULATIONS IN FAVOR OF CARDIAC MONITORING
3.2.1.4 RISE IN COST OF HEART DISEASE TREATMENT
3.2.2 RESTRAINTS
3.2.2.1 ECONOMIC DOWNTURN & MARKET SATURATION
3.2.2.2 UNSTABLE REIMBURSEMENT POLICIES
3.2.3 OPPORTUNITIES
3.2.3.1 UNTAPPED EMERGING MARKETS
3.2.3.2 M&A AND JOINT VENTURES
3.3 TRENDS & TECHNOLOGY
3.3.1 OUTPATIENT/MOBILE CARDIAC TELEMETRY (MCT)
3.3.2 ECG DATA MANAGEMENT SYSTEM (EMS)
3.3.3 HOME AED & WEARABLE CARDIOVERTER DEFIBRILLATOR
3.3.4 MRI PACEMAKER
3.4 MARKET SEGMENTATION
3.4.1 CARDIAC MONITORING DEVICES
3.4.2 CARDIAC RHYTHM MANAGEMENT DEVICES
3.5 MARKET SHARE ANALYSIS
3.5.1 ECG
3.5.2 HOLTER MONITORS
3.5.3 EVENT MONITORS
3.5.4 IMPLANTABLE LOOP RECORDERS (ILR)
3.5.5 CARDIAC OUTPUT MONITORING DEVICES
3.5.6 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD)
3.5.7 EXTERNAL DEFIBRILLATORS
3.5.8 PACEMAKERS
3.5.9 CARDIAC RESYNCHRONIZATION THERAPY DEVICES
3.6 VALUE CHAIN ANALYSIS

4 GLOBAL CONVENTIONAL CARDIAC MONITORING DEVICES MARKET
4.1 INTRODUCTION
4.2 ELECTROCARDIOGRAM (ECG)/ELEKTROKARDIOGRAMM (EKG)
4.2.1 RESTING ECG
4.2.2 STRESS ECG
4.3 HOLTER MONITORS
4.3.1 WIRED HOLTER MONITORS
4.3.2 WIRELESS HOLTER MONITORS
4.4 EVENT MONITORS
4.4.1 OUTSOURCING TO EVENT MONITORING CENTERS, A KEY GROWTH FACTOR
4.4.2 EVENT MONITORS, BY PRODUCT
4.4.2.1 POST-SYMPTOM
4.4.2.2 PRE-SYMPTOM (MEMORY LOOP)
4.4.3 EVENT MONITORS, BY TECHNOLOGY
4.4.3.1 AUTODETECT EVENT MONITORS
4.4.3.2 MANUAL EVENT MONITORS
4.5 IMPLANTABLE LOOP RECORDER (ILR)
4.6 CARDIAC OUTPUT MONITORING DEVICES
4.6.1 INVASIVE
4.6.2 MINIMALLY INVASIVE
4.6.3 NON-INVASIVE
4.6.3.1 TECHNOLOGICAL ADVANCEMENTS WILL LEAD TO AN INCREASE IN DEMAND FOR NON-INVASIVE DEVICES

5 GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
5.1 INTRODUCTION
5.2 DEFIBRILLATORS
5.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
5.2.1.1 DEMAND FOR DUAL CHAMBER ICD SET TO RISE
5.2.2 EXTERNAL DEFIBRILLATORS
5.2.2.1 DESPITE SAFETY ISSUES, EXTERNAL DEFIBRILLATORS TO SHOW POTENTIAL GROWTH
5.2.2.2 AUTOMATED EXTERNAL DEFIBRILLATORS (AED)
5.2.2.2.1 PUBLIC ACCESS AND HOME USAGE TO BOOST THE GROWTH OF AEDS
5.2.2.3 MANUAL EXTERNAL DEFIBRILLATORS (MED)
5.2.3 PACEMAKERS
5.2.3.1 RISING CASES OF HYPERTENSION TO BOOST DEMAND
5.2.3.2 PACEMAKERS, BY IMPLANTABILITY
5.2.3.2.1 IMPLANTABLE PACEMAKER
5.2.3.2.2 EXTERNAL PACEMAKER
5.2.3.3 PACEMAKERS, BY NUMBER OF CHAMBERS
5.2.3.3.1 SINGLE CHAMBER PACEMAKER
5.2.3.3.2 DUAL CHAMBER PACEMAKER
5.2.3.4 PACEMAKERS, BY TECHNOLOGY
5.2.3.4.1 TRADITIONAL
5.2.3.4.2 REMOTE
5.2.4 CARDIAC RESYNCHRONIZATION THERAPY DEVICES
5.2.4.1 CRT-DS ARE USED MORE THAN CRT-PS
5.2.4.2 MARKET MATURITY LEADING TO INNOVATIONS IN CRT DEVICES
5.2.4.3 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
5.2.4.3.1 CRT-DS ARE PREFERRED OVER ICDS
5.2.4.4 CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER (CRT-P)

6 GLOBAL CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 HOME/AMBULATORY
6.4 OTHERS

7 GEOGRAPHIC ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 CANADA
7.3 EUROPE
7.3.1 U.K.
7.3.2 GERMANY
7.3.3 FRANCE
7.3.4 ITALY
7.3.5 SPAIN
7.3.6 REST OF EUROPE (ROE)
7.4 ASIA
7.4.1 JAPAN
7.4.2 INDIA
7.4.3 CHINA
7.4.4 REST OF ASIA (ROA)
7.5 REST OF THE WORLD (ROW)
7.5.1 BRAZIL
7.5.2 OTHERS

8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 NEW PRODUCT LAUNCH
8.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES
8.4 EXPANSION
8.5 MERGERS & ACQUISITIONS
8.6 OTHERS
8.7 APPROVALS

9 COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*
9.1 BIOTRONIK SE & CO. KG
9.2 BOSTON SCIENTIFIC CORPORATION
9.3 CARDIAC SCIENCE CORPORATION
9.4 CARDIONET, INC.
9.5 ECARDIO DIAGNOSTCIS, LLC
9.6 GE HEALTHCARE (DIVISION OF GENERAL ELECTRIC COMPANY)
9.7 LIFEWATCH AG
9.8 MEDTRONIC, INC.
9.9 MIDMARK CORPORATION
9.10 MORTARA INSTRUMENT, INC.
9.11 NIHON KOHDEN CORPORATION
9.12 SPACELABS HEALTHCARE
9.13 PHILIPS HEALTHCARE
9.14 SCHILLER AG
9.15 SCOTTCARE CORPORATION
9.16 SORIN S.P.A
9.17 ST. JUDE MEDICAL, INC.
9.18 WELCH ALLYN, INC.
9.19 ZOLL MEDICAL CORPORATION
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.